Stay updated on Imatinib in Recurrent Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.

Latest updates to the Imatinib in Recurrent Psoriasis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now shows revision v3.6.6, signaling a minor update to the record; the previous revision v3.6.5 is superseded by the new version.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a platform-level update. No study content or visible information appears to have changed.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now shows Revision: v3.6.4, signaling a minor update to the page version. This change does not modify study content or user-facing information.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This change updates the page's revision tag and does not alter study content or functionality.SummaryDifference0.1%

- Check73 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2. This indicates a maintenance or patch release of the page and does not change the study content or eligibility details.SummaryDifference0.1%

- Check87 days agoChange DetectedThe study page now shows recruitment has ended ('No longer looking for participants'), and new help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study have been added.SummaryDifference0.5%

Stay in the know with updates to Imatinib in Recurrent Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.